Pfizer Inc (PFE)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $164.67B
Last updated: Nov 17, 2026 at 4:43 PM ET
Pfizer Inc (PFE) Statistics
Pfizer (PFE) has a market cap of $164.67B and an enterprise value of $225.52B. Its return on invested capital of 2.69% compares with a 13.48% median across 11 similar companies. Its dividend yield is 6.04%.
Total Valuation
Enterprise value is 36.95% above the market cap, as debt exceeds cash.
| Market Cap | $164.67B |
|---|---|
| Enterprise Value | $225.52B |
| Latest price (Nov 17, 2026) | $28.46 |
Key Dates
The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 6, 2026.
| Next Earnings Date | Feb 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Last Ex-Dividend Date | Nov 6, 2026 |
| Next Payment Date | Dec 7, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.5x and 1.8x. Its year-end P/E ranged from 7.7x to 15.7x from 2016 to 2025.
| P/E Ratio | 9.3x |
|---|---|
| Forward P/E | 9.2x |
| P/S Ratio | 2.5x |
| Forward P/S | 2.6x |
| P/B Ratio | 1.8x |
| P/FCF Ratio | 13.8x |
| P/OCF Ratio | 11.6x |
Enterprise Valuation
Counting debt and cash, the company is valued at 20.7x EBITDA and 18.9x free cash flow.
| EV / Earnings | 55.4x |
|---|---|
| EV / Sales | 3.5x |
| EV / EBITDA | 20.7x |
| EV / EBIT | 52.9x |
| EV / FCF | 18.9x |
Price Statistics
The stock is up 15.47% over 52 weeks and trades 0.04% below its 50-day average.
| Beta (1Y) | 0.29 |
|---|---|
| 52-Week Change | +15.47% |
| 1-Month Change | -1.91% |
| 3-Month Change | +2.25% |
| 6-Month Change | +12.86% |
| 5-Year Change | -30.22% |
| 10-Year Change | -3.75% |
| Total Return (1Y) | +22.45% |
| Total Return (3Y CAGR) | +2.08% |
| Total Return (5Y CAGR) | -7.74% |
| Return vs SPY (1Y) | +2.14% |
| Max Drawdown (1Y) | -16.92% |
| Max Drawdown (3Y) | -28.99% |
| Sharpe Ratio (1Y) | 0.61 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $28.47 |
| 200-Day Average | $26.45 |
| 52-Week Range | $22.76 to $30.99 |
| RSI (14 Days) | 43.1 |
| Average Volume (20 Days) | 36.23M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.42x current liabilities, and total debt is 0.70x shareholder equity.
| Current Ratio | 1.42x |
|---|---|
| Quick Ratio | 1.10x |
| Debt / Equity | 0.70x |
| Debt / EBITDA | 5.82x |
| Debt / FCF | 5.32x |
Returns and Efficiency
Return on invested capital is 2.69% over the last 12 months, against a 5-year average of 10.84%.
| Return on Equity (ROE) | 4.58% |
|---|---|
| Return on Assets (ROA) | 1.99% |
| Return on Invested Capital (ROIC) | 2.69% |
| Return on Capital Employed (ROCE) | 2.47% |
| ROE (5Y Average) | 16.39% |
| ROA (5Y Average) | 7.31% |
| ROIC (5Y Average) | 10.84% |
| Asset Turnover | 0.31x |
| Inventory Turnover | 1.70x |
| Receivables Turnover | 4.77x |
| Cash Conversion Cycle | 198 days |
Taxes
Income tax took 4.37% of pretax income over the last 12 months.
| Income Tax (TTM) | $186.00M |
|---|---|
| Effective Tax Rate | 4.37% |
Scores
PFE has an Altman Z-Score of 2.09, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.09 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $63.63B over the last 12 months is up 1.34% from the 12 months before.
| Revenue | $63.63B |
|---|---|
| Revenue Growth (YoY) | +1.34% |
| Gross Profit | $46.69B |
| Operating Income | $13.64B |
| Pretax Income | $4.26B |
| Net Income | $4.07B |
| EBIT | $4.26B |
| Reported EPS (TTM) | $3.05 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 43.51% of the $204.54B in total assets.
| Cash and Equivalents | $1.82B |
|---|---|
| Total Debt | $62.67B |
| Net Debt | $60.85B |
| Net Debt Per Share | $10.67 |
| Working Capital | $13.28B |
| Shareholder Equity | $89.00B |
| Book Value Per Share | $15.61 |
| Tangible Book Value | -$28.42B |
| Total Assets | $204.54B |
| Total Liabilities | $115.24B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $2.39B of capital spending, operating cash flow left $11.79B of free cash flow.
| Operating Cash Flow | $14.17B |
|---|---|
| Capital Expenditures | $2.39B |
| Free Cash Flow | $11.79B |
| FCF Per Share | $2.07 |
| Depreciation and Amortization | $6.50B |
| Dividends Paid | $9.79B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 21.44%, against a 5-year average of 20.74%.
| Gross Margin | 73.38% |
|---|---|
| Operating Margin | 21.44% |
| Pretax Margin | 6.69% |
| Net Margin | 6.40% |
| EBIT Margin | 6.70% |
| FCF Margin | 18.52% |
| Gross Margin (5Y Average) | 66.50% |
| Operating Margin (5Y Average) | 20.74% |
| Net Margin (5Y Average) | 17.38% |
Growth
Revenue fell 14.80% a year over 3 years, and EPS 21.12% a year.
| Revenue Growth (3Y CAGR) | -14.80% |
|---|---|
| Revenue Growth (5Y CAGR) | +8.48% |
| EPS Growth (3Y CAGR) | -21.12% |
| EPS Growth (5Y CAGR) | +3.50% |
| FCF Growth (3Y CAGR) | -29.62% |
| FCF Growth (5Y CAGR) | -5.71% |
| Operating Income Growth (3Y CAGR) | -26.44% |
| Book Value Per Share Growth (2Y CAGR) | -1.77% |
Dividends and Yields
PFE pays out 69.17% of earnings as dividends.
| Dividend Per Share (Annual) | $1.72 |
|---|---|
| Dividend Yield | 6.04% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +2.44% |
| Dividend Growth (5Y CAGR) | +2.50% |
| Payout Ratio | 69.17% |
| FCF Payout Ratio | 83.08% |
| Earnings Yield | 10.75% |
| FCF Yield | 7.27% |
| Shareholder Yield | 6.04% |
Stock Splits
The last split was a 3-for-1 forward split on Jul 1, 1999.
| Last Split Date | Jul 1, 1999 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:1 |
Peer Position
Against 9 similar companies, PFE has the lowest P/E.
P/E RatioPeer median 21.3x
P/S RatioPeer median 4.9x
ROICPeer median 13.48%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.13%
Dividend YieldPeer median 2.37%
| P/E Ratio | 9.3x vs 21.3x median |
|---|---|
| P/S Ratio | 2.5x vs 4.9x median |
| ROIC | 2.69% vs 13.48% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +1.34% vs +6.13% median |
| Dividend Yield | 6.04% vs 2.37% median |
Analyst Forecast
Consensus estimates put revenue growth at -1.41% and EPS growth at -4.46% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -1.41% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -4.46% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PFE
What is PFE's market cap?
Pfizer has a market cap of $164.67B. Its enterprise value, which adds debt and subtracts cash, is $225.52B.
What is PFE's P/E ratio?
Pfizer has a trailing P/E ratio of 9.3x and a forward P/E of 9.2x.
How many shares of PFE are outstanding?
Pfizer has 5.70B shares outstanding. The count is up 0.26% from a year earlier.
Does PFE pay a dividend?
Yes. Pfizer pays $1.72 a share a year, a dividend yield of 6.04%.
How much debt does PFE have?
Pfizer has $62.67B of total debt and $1.82B of cash and equivalents, a net debt position of $60.85B.
PFE pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts